Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
BNT162b2 Approved by FDA Experimental Vaccine Feb/03/2022 60 0
Etesevimab Potential treatment - clinical evidence Experimental Antiviral Jan/26/2022 2 11
Bamlanivimab Potential treatment - clinical evidence Experimental Antiviral Jan/25/2022 4 12
Convalescent plasma Emergency use authorization Experimental Antiviral Jan/04/2022 40 10
Budesonide Potential treatment - clinical evidence Used to treat other disease Other treatment Dec/31/2021 1 0
Chloroquine phosphate Recommended by China's NHC Guidelines Used to treat other disease Antiviral Apr/27/2021 25 9
Hydroxychloroquine sulfate Potential treatment - clinical evidence Used to treat other disease Antiviral Apr/27/2021 38 47
Camostat mesylate Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Apr/22/2021 12 1
PCI-27483 Potential treatment - pre-clinical evidence Experimental Antiviral Apr/12/2021 1 0
Soybean Trypsin Inhibitor Potential treatment - pre-clinical evidence Natural product Antiviral Apr/12/2021 1 0